- Foreword by the Director-General of Health Malaysia
- The Implementation of Bioequivalence Studies on Generic Medicines in Malaysia
- Evidence Based Energy Medicine
- Malay Postnatal Care in Hospitals
- 5th National Conference for Clinical Research Focus on Transforming Clinical Research in Malaysia
- DIA Chicago 2011 Spurs Future ASEAN Collaboration in Clinical Trials
- Generic Drugs Is Now A Matter of Policy
- Review: Lab-based Tests for Nasopharyngeal Carcinoma
- Industry Sponsored Research
- Future Events
In this issue we feature Malaysia’s move of implementing bioequivalence study requirements for generic medicines, the launch and promotion of Clinical Research Malaysia to promote clinical research and the highlights from this year’s National Conference for Clinical Research. We also discussed the lack of conclusive evidence for the therapeutic use of energy medicine and the potential of Malay postnatal care in hospitals. Finally, we included a review on Epstein Barr virus (EBV) and non-EBV related lab-based diagnosis tests for nasopharyngeal carcinoma.
>>> Read more here (PDF 927 KB, 24 pages)
|